Lilly Asia Leads in Drug Discovery Play, Createrna
23 Jun 2023
US$ 19.00
Lilly Asia Ventures has led the Rmb500 million (US$69.6 million) series A funding round of Wuhan Createrna Science and T...
Related Publications
Subscribers’ Weekly for the week ending 20 Mar 2026...
Listen to China Investments (Subscribers' Weekly 20 Mar 2026)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.